Treg cells, a subset of CD4+ T cells characterized by its ability to dampen immune responses, are attracted to the tumor stroma via chemokine receptors CCR4, CCR5, CCR6, and CCR10 [78]. The gene discussed is CD4; the disease is neoplasm.